Why the United States Still Needs Improved Dietary Supplement Regulation and Oversight | Zendy

Morrow JD | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Why the United States Still Needs Improved Dietary Supplement Regulation and Oversight

Author(s) -

Morrow JD

Publication year - 2008

Publication title -

clinical pharmacology and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.941

H-Index - 188

eISSN - 1532-6535

pISSN - 0009-9236

DOI - 10.1038/sj.clpt.6100500

Subject(s) - clinical pharmacology , dietary supplement , statement (logic) , position statement , legislation , task force , medicine , pharmacology , business , political science , law , family medicine , public administration , chemistry , food science

It has been 3 years since the American Society for Clinical Pharmacology and Therapeutics (ASCPT) issued a position statement regarding dietary supplement safety and regulation. 1 I was the Chair of the ASCPT task force charged with issuing the statement. At the time, after careful review of available data, the other members and I concluded that dietary supplement legislation in the United States was lacking and that enhanced oversight was essential to increase the safety of these products for the American consumer. Clinical Pharmacology & Therapeutics (2008) 83 , 3, 391–393.doi: 10.1038/sj.clpt.6100500

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research